Literature DB >> 8840940

Prevalence and risk factors for osteopenia in dialysis patients.

M S Stein1, D K Packham, P R Ebeling, J D Wark, G J Becker.   

Abstract

Dialysis patients are at risk for low bone mineral density (BMD) consequent of hyperparathyroidism, 1,25-dihydroxyvitamin D deficiency, previous immunosuppression, chronic acidosis, secondary amenorrhea, and chronic heparin and aluminum exposure. We wanted to determine the prevalence and distribution of osteopenia and the influence of risk factors for osteopenia in dialysis patients. Dual energy x-ray absorptiometry was used to record BMD at the lumbar spine (LS), hip, and nondominant forearm. Results were expressed as Z-scores (standard deviations from the mean of a healthy age- and gender-matched reference population). Osteopenia was defined as a Z-score worse than -2. In the 250 dialysis patients studied, the prevalence of osteopenia at the LS, femoral neck (FN) and ultradistal radius (UD) was 8%, 13% and 20%, respectively. The median Z-scores at these sites were all significantly different from the healthy reference population median of 0 and were 0.29 (P = 0.008), -0.67 (P < 0.001), and -1.01 (P < 0.001), respectively. Previous transplantation was associated with as much as a one Z-score lower BMD at the FN (P = 0.0069) and UD (P = 0.0011) and a marginally significant reduction at the LS (P = 0.0777). Previous parathyroidectomy was associated with a markedly higher LS BMD (P = 0.0001) and a higher BMD at the FN (P = 0.0017) but not the UD (P = 0.3691). A history of secondary amenorrhea was associated with a lower FN BMD (P = 0.0047) but not a significantly lower BMD at the LS (P = 0.0978) or UD (P = 0.2327). In hemodialysis patients without a history of transplantation, parathyroidectomy, or secondary amenorrhea, there was no correlation between Z-score at any site and duration of dialysis. Thus, osteopenia in dialysis patients occurs in both axial and appendicular sites and sites of compact and cancellous bone. It is more common with previous transplantation and secondary amenorrhea, whereas a history of parathyroidectomy is associated with increased BMD. No relationship was found between BMD and duration of hemodialysis, which suggests that important changes in BMD occur during the predialysis stage of chronic renal failure.

Entities:  

Mesh:

Year:  1996        PMID: 8840940     DOI: 10.1016/s0272-6386(96)90461-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  28 in total

1.  Changes in bone mineral density during the first year of dialysis treatment.

Authors:  Jose Luis Merino; Jose Luis Teruel; Milagros Fernandez; Maite Rivera; M Carmen Caballero; Joaquin Ortuño
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

2.  Changes in bone mineral density at various sites in patients on hemodialysis due to chronic glomerulonephritis.

Authors:  T Miki; A Morita; K Nakatsuka; T Tabata; T Inoue; Y Nishizawa; H Morii
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 3.  Gonadal dysfunction in chronic kidney disease.

Authors:  Biff F Palmer; Deborah J Clegg
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

4.  Operative treatment of hip fractures in patients receiving hemodialysis.

Authors:  Bilgehan Tosun; Halil Atmaca; Umit Gok
Journal:  Musculoskelet Surg       Date:  2010-09-30

5.  Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients.

Authors:  Jan Mares; Kristina Ohlidalova; Sylvie Opatrna; Jiri Ferda
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

6.  Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism.

Authors:  Esra Baskin; Seza Ozen; Musturay Karçaaltincaba; Nesrin Besbas; Umit Saatci; Ali Düzova; Pinar Isik Agras; Mithat Haliloglu; Aysin Bakkaloglu
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

7.  Bone mineral density in live related kidney transplant children and adolescents.

Authors:  Amr A el-Husseini; Amgad E el-Agroudy; Ehab W Wafa; Tarek Mohsen; Mohamed A Sobh; Mohamed A Ghoneim
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 8.  Public health approach to addressing hyperphosphatemia among dialysis patients.

Authors:  Ashwini R Sehgal; Catherine Sullivan; Janeen B Leon; Karil Bialostosky
Journal:  J Ren Nutr       Date:  2008-05       Impact factor: 3.655

9.  Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.

Authors:  Senji Okuno; Masaaki Inaba; Kayoko Kitatani; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Journal:  Osteoporos Int       Date:  2004-08-11       Impact factor: 4.507

10.  Factors associated with low bone mass in the hemodialysis patients--a cross-sectional correlation study.

Authors:  Guey-Shiun Huang; Tzong-Shinn Chu; Meei-Fang Lou; Shiow-Li Hwang; Rong-Sen Yang
Journal:  BMC Musculoskelet Disord       Date:  2009-06-04       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.